Clinical trial
HDAC Inhibitor Augmentation to Clozapine
NCT03263533 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HDAC Inhibitor Augmentation to Clozapine
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- April 30, 2017
- Completion date
- February 28, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.